The global tissue sealants market is anticipated to grow at a significant CAGR of 6.7% during the forecast period (2022-2028). The global tissue sealants market is growing due to the increased number of surgeries globally. According to an article published by ResearchGate GmbH, an estimation of 234.2 million major surgical procedures happens every year. The rising awareness to seal the wounds after injuries or surgeries as it may cause enormous blood loss is also driving the growth of the market. The rising prevalence of cardiovascular surgeries is also driving the growth of the market. According to the article published by the Centre for Disease Control and Prevention in February 2022, one person dies every 36 seconds in the US alone from cardiovascular disease. About 659,000 people in the US die from heart disease each year accounting for one in every 4 deaths.
(Get 15% Discount on Buying this Report)
A full report of Global Tissue Sealants Market is available at: https://orionmarketreports.com/tissue-sealants-market/108232/
Additionally, the improved healthcare infrastructure, as well as wide investment by major market players for research and development purposes is also boosting the growth of the global tissue sealants market during the forecast period. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new launches, to stay competitive in the market. For instance-
- In December 2021, BD announced its acquisition of Tissuemed, Ltd. to add advanced sealant to its portfolio of surgical solutions.
- In February 2020, Terumo Corp. announced the launch of a new surgical sealant AQUABRID to stop bleeding during aortic surgical procedures.
- In December 2019, Johnson & Johnson Services, Inc. launched VISTASEAL Fibrin Sealant to help surgeons manage bleeding during surgery.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Pfizer Inc., Baxter, B. Braun Melsungen AG, C. R. Bard, Inc., Tissuemed, and Cohera Medical, Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Tissue Sealants Market Report by Segment
By Type
- Fibrin-based
- Collagen-based
- Protein-based
- Synthetic Sealants
By Application
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
